Pages that link to "Q33743772"

The following pages link to Effect of tetracyclines on the dynamics of formation and destructuration of beta2-microglobulin amyloid fibrils (Q33743772):

Displaying 37 items.

• C. elegans expressing human β2-microglobulin: a novel model for studying the relationship between the molecular assembly and the toxic phenotype (Q27325393) (← links)
• Class I Major Histocompatibility Complex, the Trojan Horse for Secretion of Amyloidogenic β 2 -Microglobulin (Q27680885) (← links)
• Systemic amyloidosis: lessons from β2-microglobulin. (Q30372510) (← links)
• Polymorphism of β2-microglobulin amyloid fibrils manifested by ultrasonication-enhanced fibril formation in trifluoroethanol (Q30453082) (← links)
• A specific nanobody prevents amyloidogenesis of D76N β2-microglobulin in vitro and modifies its tissue distribution in vivo. (Q33587678) (← links)
• High throughput testing of drug library substances and monoclonal antibodies for capacity to reduce formation of cystatin C dimers to identify candidates for treatment of hereditary cystatin C amyloid angiopathy. (Q34053657) (← links)
• Characterization of the response of primary cells relevant to dialysis-related amyloidosis to β2-microglobulin monomer and fibrils (Q34077850) (← links)
• An overview of drugs currently under investigation for the treatment of transthyretin-related hereditary amyloidosis (Q34428314) (← links)
• Doxycycline hinders phenylalanine fibril assemblies revealing a potential novel therapeutic approach in phenylketonuria (Q36221601) (← links)
• Natural biomolecules and protein aggregation: emerging strategies against amyloidogenesis (Q36538570) (← links)
• Protein folding and aggregation into amyloid: the interference by natural phenolic compounds (Q37007345) (← links)
• Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2-microglobulin (Q37117146) (← links)
• Repurposing doxycycline for synucleinopathies: remodelling of α-synuclein oligomers towards non-toxic parallel beta-sheet structured species. (Q37622863) (← links)
• Clearance of extracellular misfolded proteins in systemic amyloidosis: experience with transthyretin (Q38028212) (← links)
• Distinguishing closely related amyloid precursors using an RNA aptamer (Q38305183) (← links)
• Oleuropein aglycone and polyphenols from olive mill waste water ameliorate cognitive deficits and neuropathology (Q38821665) (← links)
• Epigallocatechin-3-gallate and tetracycline differently affect ataxin-3 fibrillogenesis and reduce toxicity in spinocerebellar ataxia type 3 model. (Q38974848) (← links)
• d-Ribose glycates β2-microglobulin to form aggregates with high cytotoxicity through a ROS-mediated pathway (Q39485371) (← links)
• Epigallocatechin Gallate Remodels Overexpressed Functional Amyloids in Pseudomonas aeruginosa and Increases Biofilm Susceptibility to Antibiotic Treatment. (Q40482939) (← links)
• A covalent homodimer probing early oligomers along amyloid aggregation (Q40484665) (← links)
• Doxycycline treatment in dialysis related amyloidosis: discrepancy between antalgic effect and inflammation, studied with FDG-positron emission tomography: a case report (Q41625514) (← links)
• Lessons learned from protein aggregation: toward technological and biomedical applications. (Q46173279) (← links)
• Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis. (Q46233886) (← links)
• Small molecule-mediated inhibition of β-2-microglobulin-based amyloid fibril formation. (Q46372407) (← links)
• Using Covalent Labeling and Mass Spectrometry To Study Protein Binding Sites of Amyloid Inhibiting Molecules. (Q47657947) (← links)
• Citrate-stabilized gold nanoparticles hinder fibrillogenesis of a pathological variant of β2-microglobulin. (Q47948462) (← links)
• Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis (Q52716575) (← links)
• Reduction of conformational mobility and aggregation in W60G β2-microglobulin: assessment by 15N NMR relaxation. (Q54735249) (← links)
• Targeting Amyloid Aggregation: An Overview of Strategies and Mechanisms (Q57159243) (← links)
• CMV-Specific Immune Response-New Patients, New Insight: Central Role of Specific IgG during Infancy and Long-Lasting Immune Deficiency after Allogenic Stem Cell Transplantation (Q61796383) (← links)
• Effects of Thioflavin T and GSK-3 Inhibition on Lifespan and Motility in a Model of Tauopathy (Q64237552) (← links)
• Ultrasonication-Dependent Acceleration of Amyloid Fibril Formation (Q84758663) (← links)
• The Anti-Amyloidogenic Action of Doxycycline: A Molecular Dynamics Study on the Interaction with Aβ42 (Q90225709) (← links)
• Positron Emission Tomography Can Support the Diagnosis of Dialysis-Related Amyloidosis (Q90226200) (← links)
• C. elegans expressing D76N β2-microglobulin: a model for in vivo screening of drug candidates targeting amyloidosis (Q92289345) (← links)
• Toxicity of insulin-derived amyloidosis: a case report (Q92726690) (← links)
• CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects (Q102220321) (← links)